A webinar presented by the IBA Healthcare and Life Sciences Law Committee and supported by the European Regional Forum, the IBA Product Law and Advertising Committee and the IBA International Commerce and Distribution Committee.
Topics will include:
- The FDA, MHRA and Health Canada's role: Explore the rigorous approval mechanisms for psychedelic substances by these agencies, highlighting the nuances involved in bringing such treatments to market.
- Rescheduling psychedelics: Understand the timing and processes behind the US DEA and Canadian RCMP's potential rescheduling of psychedelics, in the event of regulatory endorsement.
- Risk Evaluation and Mitigation Strategies (REMS): Delve into REMS and its expected components, like healthcare training and informed consent protocols, that could shape the future of psychedelic-assisted treatment.
- Compliance and international impact: Review key compliance factors and consider the broader repercussions on international treaties if psychedelics gain regulatory acceptance.
- Global clinical trials: Discuss intriguing examples of psychedelic-assisted treatment trials around the world, offering insights into the therapeutic promise and challenges faced by researchers.
Fees
IBA member |
Free |
Non member |
Free |
Certificate of Attendance
Certificates of attendance for this webinar will be provided to all delegates who have registered in advance and attended the live broadcast for a minimum of 30 minutes based on verified sign-in and sign-out times. The certificate will be sent to the email address provided at the time of registration. Certificates can only be issued to the name provided at the time of registration. If you have any queries relating to your Certificate of Attendance, please email webinars@int-bar.org
Co-Moderator
Peter Wagner
Co-Moderator
Jordan & Wagner Rechtsanwaltsgesellschaft mbH, Stuttgart, Germany; Webinar Officer, International Commerce and Distribution Committee
Alan Adcock
Co-Moderator
Tilleke & Gibbins, Bangkok, Thailand; Asia Pacific Regional Forum Liaison Officer, Healthcare and Life Sciences Law Committee
Confirmed speakers
Sabrina Ramkellawan
Speaker
AxialBridge, Toronto, Ontario, Canada
Kimberly Chew
Speaker
Husch Blackwell, Oakland, California, USA
Jaspreet Grewal
Speaker
AxialBridge, Calgary, Alberta, Canada
Jonathan Deverill
Speaker
DAC Beachcroft, London, England